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ABSTRACT
Poly(A)-binding protein (PABP) is a major compo-
nent of the messenger RNA–protein complex. PABP
is able to bind the poly(A) tail of mRNA, as well as
translation initiation factor 4G and eukaryotic release
factor 3a (eRF3a). PABP has been found to stim-
ulate translation initiation and to inhibit nonsense-
mediated mRNA decay. Using a reconstituted mam-
malian in vitro translation system, we show that
PABP directly stimulates translation termination.
PABP increases the efficiency of translation termi-
nation by recruitment of eRF3a and eRF1 to the ri-
bosome. PABP’s function in translation termination
depends on its C-terminal domain and its interaction
with the N-terminus of eRF3a. Interestingly, we dis-
cover that full-length eRF3a exerts a different mode
of function compared to its truncated form eRF3c,
which lacks the N-terminal domain. Pre-association
of eRF3a, but not of eRF3c, with pre-termination com-
plexes (preTCs) significantly increases the efficiency
of peptidyl–tRNA hydrolysis by eRF1. This implicates
new, additional interactions of full-length eRF3a with
the ribosomal preTC. Based on our findings, we sug-
gest that PABP enhances the productive binding of
the eRF1–eRF3 complex to the ribosome, via inter-
actions with the N-terminal domain of eRF3a which
itself has an active role in translation termination.
INTRODUCTION
Poly(A)-binding protein (PABP) is one of the major
mRNA-interacting proteins in eukaryotes. The protein is
widespread and highly conserved among animals. Seven
isoforms of PABP were identified in humans; the most
abundant is the cytoplasmic isoform PABPC1 (1). The N-
terminal domain of PABP contains four RNA recognition
motifs (RRMs) (Figure 1A) each binding 12 adenines, while
the whole protein covers 27 adenines (2,3). RRM1 and
RRM2 are required for the specific recognition of poly(A)
stretches, whereas RRM3 and RRM4 can associate with
any RNA. RRM domains 1–4 bind the poly(A) tail from 3′
to 5′ (4). One of the main functions of the PABP is the pro-
tection of the poly(A) tail of cellular mRNAs from nucle-
ase degradation (5). Besides, the protein can associate with
other extensive poly(A) stretches like those occurring in cer-
tain 5′ untranslated regions (5′UTRs) that impact on trans-
lation initiation (6).
RRM1 and RRM2 of PABP bind to the N domain of
eukaryotic translation initiation factor (eIF) 4G (7). Thus,
PABP’s interactions with poly(A) and eIF4G together cause
the formation of the 5′ cap-eIF4E-eIF4G-PABP–poly(A)
complex where the 5′ and 3′ ends of mRNA approach each
other to form the closed-loop structure (8). Proximity of
the mRNA ends in the closed-loop structure is considered
to facilitate the reinitiation of translation, since ribosomes
are more easily engaged in the next round of initiation after
termination (9). Also, the interaction between eIF4G and
PABP is reported to increase the affinity of cap-binding fac-
tor eIF4E for the mRNAm7G cap (10,11). Thus, PABP can
be regarded as a translation initiation-stimulating factor.
The C-terminal domain of PABP (CTC) is joined with
the RNA-binding part of the protein by an unstruc-
tured proline-rich, ∼100 amino acid-long linker. The CTC
binds proteins containing PAM2 motifs. Specifically, the
PAM2 motif is found in the two main PABP regulators:
polyadenylate-binding protein-interacting proteins (Paip) 1
and 2. Paip1 stimulates the activity of PABP in transla-
tion initiation (12). Paip1 comprises PAM1 and PAM2mo-
tifs which interact with the N and C-terminal domains of
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Figure 1. PABP increases the stop codon recognition by release factors. (A) A schematic representation of the release factors and PABP constructs used
in this study. Domains involved in protein-protein interactions are indicated. Domains are color-coded and assigned functions and interaction partners
are depicted at the corresponding position below the domain. Numbers above represent amino acid positions. (B and C) Toe-print analysis of termination
complexes (TCs) formed by addition to the preTCs (B) of eRF1•eRF3a•GTP, eRF1•eRF3c•GTP, eRF1 and PABP; and of (C) eRF1•eRF3a•GMPPNP,
eRF1•eRF3c•GMPPNP, eRF1(AGQ)•eRF3a•GTP, eRF1(AGQ)•eRF3s•GTP and PABP. Release factor complexes were associated before addition to
the preTCs. Rfu––relative fluorescence unit. Positions of preTCs and TCs are labeled by white and black triangles respectively. Red stars mark the samples
where stop codon recognition is enhanced.
PABP respectively. Moreover, Paip1 interacts with eIF3g
and eIF4A (13) to form Paip1-eIF3-eIF4G and Paip1-
PABP-eIF4G complexes, which increase the stimulatory ef-
fect of PABP in translation initiation. In contrast, Paip2 is a
repressor of translation initiation (14). Paip2 also contains
PAM1 and PAM2 motifs, but complex formation decreases
PABP’s affinity to the poly(A) tail and to eIF4G, leading to
a disruption of the closed-loop structure (15).
Similar to Paip1/2, the eukaryotic release factor 3 (eRF3)
contains a PAM2 motif that recognizes the CTC domain of
PABP (16). eRF3 is one of two factors required for transla-
tion termination (17,18). eRF3 comprises an unstructured
N-terminal domain, a G domain which binds nucleotides,
as well as II and III domains which interact with the sec-
ond essential termination factor eRF1 (Figure 1A) (19).
The PAM2motif of human eRF3 is composed of two mini-
domains, PAM2.1 and PAM2.2. These mini-domains are
highly conserved among higher eukaryotes, while the re-
maining sequence of the N-terminal domain is highly vari-
able (20). The PAM2.2 mini-domain of human eRF3 has a
higher affinity for PABP when compared with the PAM2.1
mini-domain (21).
The II and III domains of eRF3 interact with the C-
terminal domain of eRF1, leading to a conformational
change in eRF1 (22). When eRF1 recognizes a stop
codon (UAG, UAA, UGA) (23), which is the first step
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of translation termination, eRF3 hydrolyzes guanosine-5’-
triphosphate (GTP). This results in a conformational rear-
rangement of eRF1 (18): TheM domain of eRF1 enters the
A-site of the large ribosomal subunit and reaches into the
peptidyl-transferase center (PTC). The second step of trans-
lation termination, which is peptidyl–tRNA hydrolysis, is
thereby triggered (24). Two human isoforms of eRF3 ex-
ist: eRF3a and eRF3b, encoded by different genes (GSPT1
andGSPT2) (25,26). Themain isoform ismost likely eRF3a
which is ubiquitously expressed; in contrast, eRF3b expres-
sion is tissue-specific (27). eRF3a and eRF3b differ with
respect to their N domains, but both proteins have con-
served PAM2.1 and PAM2.2 motifs and thus are able to
bind PABP.
PABP has been suggested to have a stimulatory effect
on translation termination and was shown to interfere with
nonsense-mediated mRNA decay (NMD) (28). Most likely,
PABP exerts its function in a position-dependent manner
(29,30). Normal stop codons are usually positioned in the
last exon of the mRNA, followed by a relatively short 3′
untranslated region (3′ UTR). In contrast, in the case of
a premature stop codon which elicits NMD a long 3′UTR
and/or an exon junction complex (EJC) is present. This
leads to a larger distance between the terminating ribo-
some and the PABP bound to the poly(A) tail. In the lat-
ter case, NMD factors can interact with the terminating
ribosome and initiate the assembly of the mRNA decay-
inducing complex. PABP was tethered to the mRNA such
that it was positioned closer to the stop codon and up-
stream of an EJC (29,30). It was shown that this led to sup-
pression of NMD (30,31). Evidence for a stimulatory effect
of PABP on translation termination is indirect: It is based
on in vivo experiments where it was found that stop codon
readthrough is increased when PABP is knocked down (29).
The effect of the PABP analog in yeast (Pab1) on trans-
lation termination is controversial: On the basis of indirect
data Pab1 is thought to decrease termination (32). However,
overexpression of Pab1 in yeast strains is suggested to acti-
vate termination of translation (33).
The molecular mechanism of PABP’s function in termi-
nation is enigmatic. Here, we characterize the impact of
cytoplasmic human PABP (PABPC1, referred to as PABP
here) on translation termination using an in vitro reconsti-
tuted mammalian translation system. We show that PABP
directly stimulates stop codon recognition in vitro and that
this function is independent of its RNA-binding activity.
The termination stimulation effect is most likely caused by
the optimal positioning of eRF3a on the ribosome, increas-
ing the efficiency of eRF1 to recognize stop codons and to
catalyze peptidyl–tRNA hydrolysis in the PTC.
MATERIALS AND METHODS
Ribosomal subunits and translation factors
The 40S and 60S ribosomal subunits, as well as eu-
karyotic translation factors eIF2, eIF3, eIF4F, eEF1H
and eEF2, were purified from rabbit reticulocyte lysate
as described (18). The human translation factors eIF1,
eIF1A, eIF4A, eIF4B, eIF5B, eIF5, PABP, PABP lack-
ing RRM1––RRM4motifs (first 375 amino acids residues),
eRF1, eRF1(AGQ) and eRF3c lacking the N-terminal do-
main (138 amino acid residues including PAM2) were pro-
duced as recombinant proteins in Escherichia coli strain
BL21 and subsequently purified via Ni-NTA agarose and
ion-exchange chromatography (18).
Expression and purification of human eRF3a
Human full-length eRF3a (GSPT1) was cloned into the
pFastBac-Htb vector (Life Technolgies) and expressed in
insect cells Sf21 using the EMBacY baculovirus from the
MultiBac expression system (34). Cells were lysed by son-
ication in 20 mM Tris–HCl pH 7.5, 100 mM KCl, 6 mM
-mercapthoethanol, 0.1% Tween-20 and 5% glycerol sup-
plemented with protease inhibitors. eRF3a was purified by
affinity chromatography using a HisTrap HP column (GE
Healthcare) followed by anion-exchange chromatography
using a MonoQ column (GE Healthcare). In the final size-
exclusion chromatography step (Superdex-200 column, GE
Healthcare) using 20 mMTris–HCl pH 7.5, 100 mMKCl, 6
mM beta-mercapthoethanol, 0.1% Tween-20 and 5% glyc-
erol, the protein elutes as a monomer.
In vitro transcription of mRNA
The mRNA was transcribed in vitro using T7 RNA poly-
merase. The MVHL-stop plasmid contains a T7 promoter,
four CAA repeats, the -globin 5′-UTR, open reading
frame (encoding for the peptide MVHL), followed by the
UAA stop codon with the various next base (U,A,G,C) and
a 3′-UTR comprising the rest of the natural -globin cod-
ing sequence (35). For run-off transcription the MVHL-
stop plasmid was linearized by restriction digest with XhoI.
The MVHC–polyA plasmid contains a T7 promoter, four
CAA repeats, an MVHC open reading frame followed by
anUAA stop codon, the complete human -globin 3′-UTR
and polyA tail (70 nucleotides). For run-off transcription
mRNA plasmids were linearized with EcoRI.
Pre-termination complex assembly and termination analysis
Pre-termination complexes (preTCs) were assembled in
vitro as described (36) and used in peptide release assays
and conformational rearrangement analyses by toe-print
assays (37). For peptide release assays aliquots containing
0.2 pmol of the preTCs were incubated at 37◦C for 3 min
with 0.6 pmol of eRF1/3 and 5 pmol of PABP. For con-
formational rearrangement analyses aliquots containing 0.2
pmol of the preTCs were incubated at 37◦C for 15 min
with 0.6 pmol of eRF1/3 and 5 pmol of PABP or 7 pmol
of PABP. In case of preTC assembly in the presence of
PABP––18 pmol MVHC–polyA and/or 18 pmol MVHL
mRNA were used and incubated with 80 pmol PABP at
37◦C for 2 min before preTC formation. For toe-print as-
say of MVHL and MVHC–polyA mRNAs, 5′-FAM la-
beled toe-primers 1 (5′-GCATGTGCAGAGGACAGG-3′)
and 2 (5′-GCAATGAAAATAAATTCC-3′) were used re-
spectively.
preTC binding assay
Purified preTCs (160 l) were incubated with 3.5 pmol
eRF1(AGQ), 10 pmol eRF3a or eRF3c, 200 pmol PABP
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in buffer with 0.2 mM GTP and with 0.2 mM MgCl2 at
37◦C for 10 min (37). Pre-incubation of PABP with eRF3
was performed to exclude a preliminary binding of eRF3
with eRF1, which can decrease the termination activity of
eRFs (Figure 3). The reaction volume was 500 l. Subse-
quently, TCs were incubated with 1% formaldehyde at 4◦C
for 1 h (38). Glycinewas added up to 0.1M to stop the cross-
linking reaction. The TCs were purified in a 10–30% (w/w)
linear sucrose density gradient (SDG) as described above.
The gradients were fractionated into 14 equal fractions fol-
lowed by precipitation in 10% trichloroacetic acid (TCA).
The protein pellets were dried and analyzed by western blot.
RESULTS
PABP stimulates stop codon recognition activity of release
factors
PABP and eRF3a were shown to interact directly (16).
Therefore, we decided to determine how PABP affects the
activity of eRF3a and eRF1 in translation termination. In
the presence of PABP, both release factors were added to
preTCs which were assembled in vitro from individual com-
ponents on the MVHL mRNA and purified by SDG cen-
trifugation. We then performed toe-print analyses of the
ribosomal complexes in order to assess stop codon recog-
nition and termination complex (TC) formation. In Sup-
plementary Figure S1, we show examples of raw data of
the toe-print analyses, obtained by capillary electrophore-
sis of cDNA products generated with fluorescently labeled
primers. During stop codon recognition of eRF1, the ribo-
some protects additional nucleotides on the mRNA, which
can be detected in toe-printing assays as a two-nucleotide
shift of the ribosomal complex (18,39,40).
Our preTCs contain a UAA stop codon in the ribosomal
A-site. Addition of release factors leads to the appearance
of a peak, corresponding to the TC. For our experiments, we
applied limiting concentrations of release factors (0.6 pmol
of eRF1 and eRF3a/c) such that the 2-nt shift of the riboso-
mal complexwas rather inefficient. This allowed us to detect
any enhancement of release factor activity in the presence of
PABP.
Addition of 5 pmol PABP, release factors and GTP to
the preTCs significantly increases the 2-nt shift, i.e. PABP
stimulates stop codon recognition (Figure 1B). This stim-
ulatory effect is specific, as it is observed only after the
addition of full-length eRF3 (eRF3a) to the reaction: the
N-terminally truncated version, eRF3c, which is unable to
bind PABP does not show any stimulation of stop codon
recognition.Moreover, the stimulatory effect of PABP is not
observed in the absence of release factors, or in the pres-
ence of eRF1 only (Figure 1B). Addition of PABP to the
preTCs in the presence of higher amounts of eRFs (5 pmol
of each, corresponding to a 25-fold molar excess of eRFs
over preTCs) also stimulates stop codon recognition, but
the effect is rather weak (Supplementary Figure S1B).
Our model MVHL mRNA contains an uracil nucleotide
(U) in the +4 position after the stop codon. Recently, it
was shown that eRF1 binding to a stop codon in the de-
coding site leads to a conformational change in the 18S
rRNA which pulls the +4 nt into the decoding site (39,40).
This compaction due to mRNA U-turn motif formation
is the basis of stop codon recognition by eRF1. It pulls
downstream mRNA further into the mRNA channel and
thus provides an explanation for the toe-printing peak shift,
which is observed upon TC formation (Figure 1B) (39,40).
We tested the effect of the stop codon context on stimulation
of stop codon recognition by PABP: we generated three ad-
ditional model mRNAs with the various nucleotides (ade-
nine, guanine and cytosine) in the fourth position. We as-
sembled preTCs on these mRNAs and used them for toe-
printing assays in the presence and absence of PABP (Sup-
plementary Figure S2). We found that in all possible con-
texts of the UAA stop codon, PABP equally stimulates stop
codon recognition.
Notably, the same stimulatory effect of PABP on stop
codon recognition is observed when a non-hydrolysable
analog of GTP (GMPPNP) is added to the reaction (Fig-
ure 1C). Similarly, PABP stimulates stop codon recogni-
tion in the presence of eRF3a and an AGQ mutant of
eRF1 (eRF1(AGQ)), which is unable to hydrolyze peptidyl–
tRNA (Figure 1S). We conclude that PABP activates TC
formation independently of GTP or peptidyl–tRNA hy-
drolysis. This suggests that the stimulatory effect of PABP
on translation termination occurs when the release factors
bind to the ribosome and recognize the stop codon.
PABP stimulates stop codon recognition as a cis- and trans-
acting factor
We demonstrate in Figure 1 that PABP activates stop codon
recognition on the model mRNA lacking a poly(A) tail
(MVHL). However, within cells, most molecules of PABP
are bound to the poly(A) tail of mRNAs. Therefore, we de-
cided to investigate whether the poly(A) binding of PABP
affects its stimulation of translation termination. Therefore,
we used MVHC–polyA mRNA which contains the same
leader sequence as MVHL mRNA (but a different coding
sequence (MVHC)), as well as anUAA stop codon followed
by the -globin 3′UTR and by the poly(A) tail. Different
3′UTRs were used to distinguish cDNA products produced
by toe-printing primers 1 and 2 in the mixture of mRNAs
(see below).
The MVHC–polyA mRNA was first incubated with
PABP and then used for preTC assembly (Figure 2A). Sub-
sequently, the preTCs were purified by SDG centrifuga-
tion, subjected to termination reactions and tested in toe-
printing assays. We speculate that the different 3′UTR se-
quence in the MVHC–polyA mRNA leads to a differ-
ent mobility of the corresponding cDNAs, and TC forma-
tion is detected as +1 nt toe-print shift for the MVHC–
polyA construct (Figure 2 A, B and Supplementary Fig-
ure S3). The addition of release factors to preTCs, assem-
bled on MVHC–polyA mRNA and incubated with PABP,
results in a more efficient stop codon recognition of the
eRF1•eRF3a complex compared to the eRF1•eRF3c com-
plex (Figure 2A). In the absence of PABP, the activities
of eRF3a and eRF3c in stop codon recognition are very
low and almost equal using the MVHC–polyA construct
and limiting amounts of eRFs (Supplementary Figure S3).
As a control, we assembled preTCs on MVHL mRNA
in the presence of PABP and found almost no differences
in stop codon recognition in the presence of eRF3a ver-
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Figure 2. PABP increases the stop codon recognition by release factors in cis and trans. Toe-print analysis of TCs formed by addition to the preTCs
of eRF1(AGQ)•eRF3a•GTP or eRF1(AGQ)•eRF3s•GTP. (A) MVHC–polyA or MVHL mRNAs were incubated with PABP separately and used for
reconstitution of preTCs. (B) The mixture ofMVHC–polyA andMVHLmRNAs was incubated with PABP and used for reconstitution of preTCs. Release
factor complexes were associated before addition to preTCs. Rfu––relative fluorescence unit. Positions of preTC and TC are labeled by white and black
triangles respectively. (C) Western blot analysis of fractions after SDG of preTCs assembled on the mixture of MVHL andMVHC-polyA (lane 1), MVHL
(lane 2) orMVHC–polyA (lane 3) mRNAs in the absence (lane 1) or presence (lanes 2 and 3) of PABP. Stars mark the samples where stop codon recognition
is enhanced.
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Figure 3. PABP increases the efficiency of peptidyl–tRNA hydrolysis in the presence of release factors. (A) Hydrolysis of peptidyl–tRNA induced by
the addition of eRF1 and eRF3 or their preformed complexes. GTP was added first to the reaction. (V) Hydrolysis of peptidyl–tRNA induced by the
eRF1•eRF3a or eRF1•eRF3s complexes in the presence/absence of PABP. In experiments 1, 2, 5 and 6, GTP was added to preTCs before the eRFs. In
most cases proteins added to the preTCs were pre-associated. The only exceptions are the experiments in panel 3A (lines 1 and 3), where eRF3a/c were
pre-incubated with the preTC first (highlighted in gray). n corresponds the number of measurement repeats. The stars (**) mark a significant difference
from the respective control P < 0,01.
sus eRF3c (Figure 2A). Moreover, the efficiency of stop
codon recognition was similar, irrespective of incubation
of MVHL mRNA with PABP (Supplementary Figure S3
and Figure 2A). Western blot analysis of the SDG-purified
preTCs shows that PABP binds only very weakly to preTCs
assembled on MVHL mRNA and more efficiently binds to
the PreTCs assembled on MVHC–poly(A) mRNA (Figure
2C, compare lanes 2 and 3). Thus, the amount of PABP un-
specifically bound toMVHLmRNA is apparently not suffi-
cient to detectably activate translation termination (Figure
2A). Taken together, these experiments show that PABP re-
mained bound to theMVHC–poly(A) mRNA during SDG
(Figure 2C) and stimulated stop codon recognition in cis by
interaction with the N-terminal domain of eRF3a.
To test whether PABP can also act in trans, MVHC–
poly(A) mRNA was mixed with equal amounts of MVHL
mRNA and incubated with PABP. After preTC assembly
and SDG purification, translation termination reactions
were performed followed by toe-printing assays (Figure 2B).
The toe-printing results show that stop codon recognition
is enhanced for both preTCs. Thus, PABP bound to the
poly(A) tail of MVHC–polyA mRNA is able to stimulate
termination on the own mRNA (i.e. in cis) and on preTCs
with MVHL mRNA (e.g. in trans) (Figure 2B). The ob-
served stimulation is specific because it depends on the pres-
ence the N-terminal domain of eRF3a and accordingly is
not observed for eRF3c.
PABP increases peptidyl–tRNA hydrolysis by the release fac-
tors
To test whether PABP also affects the peptidyl–tRNA hy-
drolysis reaction we assembled preTCs on the MVHL
mRNA using S35-labeled initiator-tRNA. The efficiency of
peptidyl–tRNA hydrolysis was determined by quantifica-
tion of the radioactive MVHL peptide released from the ri-
bosomal complexes. We observed that the efficiency of pep-
tide release depends on the order of addition of release fac-
tors to the preTCs. Incubation of eRF3a with the preTCs
andGTP, followed by addition of eRF1, causes effective ter-
mination. In contrast, addition of the pre-associated com-
plex of eRF1 and eRF3a to the preTCs decreases termi-
nation efficiency by a factor of ∼20 (Figure 3A compare
lanes 1 and 2). In the same experiment using eRF3c, the
efficiency of termination does not depend on the order of
factor addition and the peptide release measured after pre-
incubation with eRF3c with preTCs, followed by eRF1 ad-
dition was virtually identical to the addition of the pre-
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associated eRF1•eRF3c complex or eRF1•eRF3a complex
to preTCs (Figure 3A compare lanes 2,3,4). Thus, the ob-
served high efficiency of peptide release requires the N-
terminal part of eRF3a.
Pre-association of PABP with the eRF1•eRF3a complex
stimulates peptidyl–tRNA hydrolysis by approximately 8-
fold (Figure 3B, lanes 1 and 2). In contrast, incubation of
PABPwith the eRF1•eRF3c complex does not significantly
affect the efficiency of peptide release (Figure 3B, lanes 5
and 6). We found that the optimal condition for translation
termination is the addition of eRF1 after the pre-incubation
of eRF3a with the preTCs. Under these conditions, PABP
does not change the efficiency of peptide release (Supple-
mentary Figure S4B). However, when we use limiting con-
centrations of eRFs (three times lower) and the same order
for the addition of release factors, the level of peptide re-
lease diminishes significantly. Under these sub-optimal con-
ditions, PABP exerts a stimulating effect on termination
and increases the efficiency of peptidyl–tRNA hydrolysis
∼2-fold (Supplementary Figure S4B). In summary, PABP
has a stimulatory effect when the termination efficiency is
reduced, for instance due to limiting eRF concentrations
or due to the formation of eRF1•eRF3a complexes which
seem to be less active in termination.
Notably, pre-association of GTP with eRF1•eRF3a in-
creases the efficiency of peptide release (Figure 3B, lane 3).
Formation of eRF1•eRF3a•GTP•PABP complexes also
results in a pronounced, 11-fold stimulatory effect on trans-
lation termination indicating a moderate additional stim-
ulatory effect compared to eRF1•eRF3a•GTP complexes
(7-fold) or eRF1•eRF3a•PABP complexes (8-fold) (Figure
3B, compare lane 4 to lanes 2 and 3).
The C-terminal domain of PABP is essential for improved ef-
ficiency of stop codon recognition
We generated an N-terminally truncated PABP protein
(PABP) lacking the four RRMs which are necessary to
bindmRNA (Figure 1A). The deletion of the RNA-binding
motifs of PABP allows assessing whether the RRMs are re-
quired for stop codon recognition. PABP comprises the
unstructured proline-rich linker and theCTCdomainwhich
is able to interact with PAM2 motif of eRF3a (41). To de-
termine an effect of PABP on stop codon recognition, we
performed toe-printing assays with reconstituted preTCs
on MVHL mRNA. We observed that PABP also pro-
moted stop codon recognition upon addition to eRF1 and
eRF3a, although less efficiently than the full-length PABP,
requiring high PABP concentrations to achieve a visible
effect (compare Figures 1B and 4). The stimulatory effect
on stop codon binding can be reproduced in the presence
of GMPPNP, which was added instead of GTP (Figure
4). These experiments indicate that the C-terminal part of
PABP is required for stimulation of stop codon recognition.
PABP promotes binding of eRF3a to preTCs
In order to study how PABP affects the interaction of
release factors with ribosomes and improves stop codon
recognition we tested the ability of this protein to bind
preTCs in the presence or absence of eRFs (Figure 5).
Figure 4. The C-terminal part of PABP (PABP) stimulates stop
codon recognition by release factors. Toe-print analysis of TCs
formed in the presence of eRF1•eRF3a•GTP, eRF1•eRF3c•GTP,
eRF1•eRF3a•GMPPNP, eRF1•eRF3c•GMPPNP in the absence (above)
and presence (below) ofPABP. Release factor complexes were associated
before addition to the preTCs. Rfu––relative fluorescence unit. Positions
of preTCs and TCs are labeled by white and black triangles respectively.
Red stars mark the samples where stop codon recognition is enhanced.
PreTCs were incubated with PABP, eRF1(AGQ), eRF3a or
eRF3c, and GTP. Subsequently, the complexes were cen-
trifuged into an SDG.After fractionation, the proteins were
detected by western blotting. The eRF1(AGQ) mutant was
used to stabilize TCs, since this mutant is able to bind the
stop codon, but is inactive in peptide release. Therefore, it
can stabilize the TCs.
PreTCs migrate in fractions 10–14 (Supplementary Fig-
ure S5A). To exclude aggregation of proteins in solution,
we determined their distribution in the SDG in the ab-
sence of ribosomes (Supplementary Figure S5B). All pro-
teins (eRF1, eRF3a, eRF3c and PABP and their complexes)
are detected only in the top fractions of the gradient (frac-
tions 1–5). PABP can interact with preTCs. However, the
complex is likely low affinity and dissociates during SDG.
Accordingly, PABP is found not only in fraction 1–3 (Sup-
plementary Figure S5B), but also in fractions 4–9 in the
presence of preTCs (Supplementary Figure S5C).
In the absence of PABP, both eRF3a and eRF3c do not
form stable complexes with the preTCs, irrespective of the
presence (Figure 5A) or absence of eRF1 (Figure 5B). The
presence of PABP in the binding reactions stabilizes the
binding of eRF3a to preTCs (Figure 5). In contrast, eRF3c
is still not found in the preTC fractions despite the addition
of PABP. This was expected because PABP does not inter-
act with either eRF3c or eRF1. It is important to note that
the interaction of eRF1(AGQ) with the preTCs is indepen-
dent from the addition of PABP and from the eRF3 variant
(full-length versus truncated).
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Figure 5. eRF3a and PABP bind preTCs cooperatively. (A) Western blot analysis of TC fractions after SDG of preTCs incubated with GTP, eRF1(AGQ)
(upper panel) and eRF3a (left) or eRF3c (right) in presence of PABP (lower panel). Antibodies raised against eRF1, eRF3 and PABP were used for
detection. (B) Western blot analysis of preTCs incubated with eRF3a +GTP (above) and eRF3a•PABP +GTP (below) using antibodies against eRF3 and
PABP. The fractions of the SDG are indicated above the Western blots; fraction 1 corresponds to the top of the gradient, 14 to the bottom. Boxes indicate
the fractions that contain ribosomal complexes.
We conclude that PABP stabilizes the binding of eRF3a
to ribosomal complexes. This finding is in agreement with
the stimulating effect of PABP on stop codon recognition
and peptidyl–tRNA hydrolysis induced by the release fac-
tors (Figures 1 and 4).
DISCUSSION
PABP is an important player in eukaryotic translation and
its control (42). The role of PABP in stimulation of trans-
lation initiation is well-established (10). However, the func-
tions of PABP in translation are not limited to regulation
of initiation. Several studies suggest that PABP interferes
with NMD and that PABP deletion increases read-through
of stop codons, thereby indirectly providing evidence for a
role of PABP in stimulation of termination (29–31). Here
we show, that PABP directly stimulates translation termina-
tion in vitro, confirming PABP’s role as a regulatory factor
in translation termination.
Using a reconstituted in vitro translation system we show
that PABP stimulates the stop codon recognition activity of
eRF1 in the presence of full-length eRF3a (Figure 1). Ap-
parently, this PABP activity is independent of GTP hydrol-
ysis by eRF3a. It can be observed in the presence of a non-
hydrolysable GTP analog (GMPPNP) and independent of
peptidyl–tRNA hydrolysis, which is inhibited by GMPPNP
and by the eRF1(AGQ) mutant (Figure 1B). Moreover, it
is independent of the stop codon context (Supplementary
Figure S2). In addition, PABP increases the efficiency of
peptidyl–tRNA hydrolysis under non-optimal termination
conditions, e.g. the formation of eRF1•eRF3a complexes
(Figure 3B) or in the presence of limiting amounts of release
factors (Supplementary Figure S4B). We show that PABP
does not interact with eRF1 directly, but exerts its effect via
eRF3a (Figure 1B). Taken together, our experiments show
that PABP increases the efficiency of stop codon recogni-
tion leading to enhanced formation of TCs. PABP interacts
with the N-terminus of eRF3a and the GTPase activity of
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eRF3a is not required for stimulation. Therefore, we sug-
gest that the observed increase in efficiency of peptide re-
lease is a consequence of more efficient TC formation. Im-
portantly, the observed stimulatory effect does not depend
on the RNA-binding motifs of PABP (Figure 4). The C-
terminal part of PABP comprising the proline-rich linker
and the CTC, is sufficient to elicit increased TC formation
in toe-print assays. However, it should be noted that RRM
motifs of PABP can participate in the stimulation of termi-
nation by binding to the poly(A) tail and thereby position-
ing PABP closer to the preTCs. Indeed, we demonstrated
that the cis-action of PABP in the presence of a mRNA
with a poly(A) tail requires significantly less PABP and thus
is more efficient compared to the trans-reaction (compare
Figures 1 and 2).
We observe that PABP stabilizes the binding of eRF3a
to the ribosome (Figure 5). eRF3a is not associated with
the TCs after sucrose gradient centrifugation, most likely
it dissociates from the complexes in the SDG. In the pres-
ence of PABP, eRF3a can be detected in the ribosome-
containing fractions indicating that the binding of eRF3a
to ribosomes is stabilized by PABP. Previous studies showed
that PABP specifically binds ribosomes in vivo (43–45). For
yeast PABP (Pab1), a specific interaction was shown with
the 60S subunit via the C-terminal part of Pab1 comprising
the linker region and CTC domain (43). Moreover, it has
been suggested that Pab1 interacts with the ribosomal pro-
tein rpL39, which is located near the exit of the ribosomal
tunnel (44). It should be noted that the linker sequences of
the yeast and human PABP are very different, therefore this
interaction might not be conserved from yeast to human.
Furthermore, rpL39 is located very distant from the eRF3-
binding site on the ribosome (46). We assume that the rele-
vant ribosomal binding site for human PABP is not rpL39,
but close to the ribosomal A site.
Fundamental differences may exist concerning the role
of human PABP and yeast Pab1 in translation termination.
However, the exact role of Pab1 in termination is enigmatic:
in dual luciferase assays increased stop codon read-through
is observed in the presence of Pab1. This is likely due to in-
teraction of Pab1 and eRF3 leading to decreased termina-
tion efficiency (32). Based on this, it was suggested that Pab1
is required for maintaining a basic level of read-through in
yeast. In contrast, an earlier study showed that overexpres-
sion of Pab1 in yeast strains with a mutant eRF3 causes
an anti-suppression effect indicating that the interaction of
eRF3 and Pab1 stimulates translation termination (33). Im-
portantly, yeast eRF3 interacts via the N and M domains
with the linker and C domain of Pab1 (32). This indicates
that the underlying protein–protein interactions andmolec-
ular mechanisms differ between yeast and human.
Interestingly, we observe that theNdomain of eRF3a sig-
nificantly enhances translation termination, even in the ab-
sence of PABP. Pre-association of full-length eRF3a with
the preTCs dramatically increases the efficiency of transla-
tion termination compared to the N-terminally truncated
variant (eRF3c) (Figure 3). The latter was used in most
previous termination studies (see below). Pre-association of
eRF1•eRF3a complexes in solution abolishes the stimulat-
ing effect of the eRF3a N domain on termination (Figure
3A).However, addition of PABPorGTP to these complexes
partly resumes the activity of full-length eRF3a (Figure 3B).
It should be noted that the N-terminal parts of eRF3a and
eRF3b vary widely between different species but the PABP-
binding motif (PAM2) is conserved (21).
Previous in vitro characterizations of release factor activ-
ity and all available structures of TCs used truncated eRF3c
which is unable to bind PABP, but is active in termination.
Until now, the activity of eRF3c was considered to be iden-
tical to the one of full-length eRF3a and eRF3b, and thus
the N-terminal part of eRF3 was assumed to be dispens-
able for termination due to its sequence variability (47). This
hypothesis is based on a thermodynamic study of eRF1,
eRF3a and nucleotide interactions that showed no effect
of the N domain of eRF3a on the eRF1–eRF3 association
constant in the absence of the ribosome (21). Importantly,
the authors noted a change in entropy and enthalpy of the
eRF1–eRF3 interaction depending on the presence of the
N domain of eRF3. This was interpreted as an enthalpy–
entropy compensation, meaning that interactions of eRF1
with either eRF3c or eRF3a use different pathways, but
reach the same final state. Notably, that this study was per-
formed in the absence of the ribosome and the association
constant of the full-length eRF3a with the ribosome was
not determined. Our data indicates that the N domain of
eRF3a plays an important role in peptidyl–tRNA hydroly-
sis and that it is essential for the stimulation of termination
by PABP.
We observe that the association of eRF1 with eRF3a in
solution prevents efficient binding of the release factors to
the preTCs (Figure 3A). One possible explanation could be
an unspecific interaction of eRF1 with the N domain of
eRF3a. Based on structural data, the PAM2 motif is con-
sidered unstructured (41). eRF1–eRF3a interactions may
lead to an unfavorable conformation for ribosome binding.
Our data, showing a role of the N domain of eRF3a in
translation termination, changes the current concept of ter-
mination in higher eukaryotes. Based on our findings, we
propose a model for the interaction of release factors with
the preTCs and the impact of PABP (Figure 6). We sug-
gest that PABP can specifically bind to the N domain of
eRF3a and thereby recruits eRF3a to the preTCs. Possibly,
PABP promotes the correct orientation of eRF3a and eRF1
on the ribosome, allowing efficient stop codon recognition.
To exert this effect, PABP needs to interact with the ribo-
some near the factor binding site. Otherwise, PABP could
not stimulate termination and would reduce the pool of free
eRF3a which would interfere with termination. Efficient
peptidyl–tRNA hydrolysis in the presence of PABP may be
a consequence of the increased stop codon recognition.
In vivo, a ribosome encountering a normal stop-codon
is assumed to be in close vicinity to the poly(A) tail which
is bound by PABP (Figure 6). Here, we show that in vitro
PABP triggers eRF3a binding to ribosomes via its C-
terminal domain and thus helps to recruit eRF3a and eRF1.
We demonstrate that through the interaction of PABP with
the N-terminal domain of eRF3a, the stop codon recogni-
tion and peptidyl–tRNA hydrolysis is stimulated under lim-
iting concentrations of eRFs which is likely to be the case in
vivo. Moreover in vivo, PABP is suggested to compete with
NMD factor UPF1 for eRF binding thus interfering with
NMD. In cases, where the 3′UTR is very long, or when an
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Figure 6. Model for PABP-stimulated translation termination. In the presence of PABP, eRF3a binds efficiently to preTCs and optimally positions eRF1
in the ribosomal complex for stop codon recognition. Accordingly, the termination efficiency is high as indicated by more efficient peptide release. When
PABP is pre-bound to the mRNA, it recruits eRF1/3a to the preTCs, thus increasing the local eRF1/3a concentration and stabilizing the eRF binding to
the ribosome.
EJC is bound in the 3′UTR, UPF1 may outcompete PABP
for preTC binding and trigger mRNA decay (29–31).
In summary, we show here that the N-terminus of eRF3a
is important for translation termination in the presence and
absence of PABP. The C-terminal part of PABP is suffi-
cient for stimulation of stop codon recognition. PABP en-
hances eRF3a ribosome binding, stop codon recognition
and peptidyl–tRNA hydrolysis. The increased efficiency of
TC formation ismost likely achieved by optimal positioning
of eRF3a on the ribosome.
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